A coalition of plaintiffs' law firms including Williams Hart & Boundas, Waters Kraus Paul & Siegel, Motley Rice, Seeger Weiss, and the Holland Law Firm has achieved a $7.25 billion settlement class action against Monsanto. The settlement, filed on February 17, 2026, in the City of St. Louis Circuit Court, aims to resolve thousands of existing and future claims involving Roundup exposure and non-Hodgkin lymphoma.
The agreement establishes a structured compensation framework for individuals diagnosed with NHL following exposure to Monsanto's glyphosate-based herbicide. This development comes after years of litigation during which juries nationwide returned significant verdicts linking Roundup to the cancer, while tens of thousands of claims remain pending in state and federal courts.
John Eddie Williams, Jr., Founding and Managing Partner of Williams Hart & Boundas, LLP, stated that the settlement represents an acceptable resolution given current circumstances, particularly as the U.S. Supreme Court has accepted an appeal to review the validity of Roundup claims. According to the settlement terms, Monsanto will fund up to $7.25 billion to compensate a class that includes virtually all existing and certain future Roundup cancer claims.
The proposed settlement provides eligible class members with the right to opt out and pursue their claims individually if they choose. For more information about the settlement, please contact Williams Hart & Boundas, LLP at 713-940-6220. The case is filed in St. Louis city court. The structured and comprehensive resolution framework is designed to address the complex legal landscape surrounding glyphosate-based herbicides and their alleged health impacts.
This settlement represents one of the largest mass tort resolutions in recent history and has significant implications for the agricultural chemical industry. The agreement may influence how corporations approach product liability litigation involving widely used consumer and agricultural products. For business leaders, this case demonstrates the substantial financial risks associated with mass tort litigation and the importance of comprehensive risk assessment for products with potential long-term health implications.
The resolution also highlights the evolving legal landscape surrounding chemical exposure claims and establishes a precedent for structured settlement frameworks in complex mass tort cases. Industry observers will be watching how this settlement affects ongoing regulatory discussions about glyphosate and similar chemicals, as well as how it might influence corporate approaches to product safety and liability management in the agricultural technology sector.
